← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 23, 2020Last known activity
Dec 1, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 8 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (13)
- NCT05136924Lead sponsorPhase 2Dec 1, 2021
- NCT05082974Lead sponsorPhase 3Oct 15, 2021
- NCT05045508Overall official - principal investigatorPhase 3Aug 30, 2021
- NCT05045508Sponsor investigatorPhase 3Aug 30, 2021
- NCT05045508Lead sponsorPhase 3Aug 30, 2021
- NCT05023304Lead sponsorPhase 4Aug 23, 2021
- NCT05023304Sponsor investigatorPhase 4Aug 23, 2021
- NCT04725747Reponsible party - principal investigatorPhase 4Jan 25, 2021
- NCT04725747Lead sponsorPhase 4Jan 25, 2021
- NCT04549935Lead sponsorPhase 4Sep 14, 2020
- NCT04396990Lead sponsorPhase 4May 15, 2020
- NCT04396990Reponsible party - principal investigatorPhase 4May 15, 2020
- NCT04281862Lead sponsorPhase 4Jan 23, 2020
Details
- Last known activity
- Dec 1, 2021